- CEO
- Roger A. Dartt
- Full Time Employees
- 12
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Address
- 5655 Bear Lane Corpus Christi TX United States of America 78405
- IPO Date
- Oct 31, 1994
- Business
- American Medical Technologies Inc operates as a medical device manufacturing company specializing in the design, development, and production of innovative medical technologies and products for healthcare applications. The company's core offerings include advanced medical devices and equipment targeting multiple therapeutic areas and clinical needs, emphasizing cutting-edge technology and custom solutions for hospitals, clinics, and healthcare providers primarily in the United States and international markets. Founded in 1995 and headquartered in Bridgeport, Connecticut, American Medical Technologies services a broad base of medical facilities with its portfolio of diagnostic and therapeutic devices, surgical instruments, and patient monitoring systems.
In recent years, the company has focused on strategic expansion through the launch of new medical device lines and the formation of partnerships aimed at integrating artificial intelligence and advanced data analytics into its product offerings to enhance clinical outcomes and operational efficiencies. In 2024 and 2025, American Medical Technologies secured significant partnerships with major healthcare technology firms to accelerate innovation in diagnostic accuracy and remote patient monitoring, reflecting a shift toward digital health integration. The company also completed a notable acquisition of a smaller medical device startup specializing in AI-driven diagnostics, reinforcing its commitment to leveraging tech-enabled solutions as a growth driver.
As part of its latest operational developments, American Medical Technologies has invested heavily in expanding its manufacturing capacity and capabilities with advanced automation and quality control measures to meet increasing global demand. These efforts coincide with enhanced regulatory compliance initiatives and market entry strategies for Europe and Asia, aimed at broadening its geographic footprint and accessing new revenue streams in emerging healthcare markets. The company's continuous focus on research and development, along with strategic alliances and acquisitions, positions it as a competitive player in the evolving medtech landscape.